health canada approval zepbound tirzepatide obesity canada date Weight-loss drug approved to treat sleep apnea in Zepbound coverage with PSHCP :

According to the Medicines and Healthcare products Regulatory Agency (MHRA) and the European Medicines Agency (EMA) , Victoza is indicated as an adjunct to diet and exercise to improve glycaemic control

In clinical studies, tirzepatide has shown even greater average weight loss than semaglutide alone

In the UK, from early 2024 to early 2025, approximately 1.6 million adults in England, Wales, and Scotland used GLP-1 class drugs for weight loss, including semaglutide drugs like 'Wegovy' and 'Ozempic', or tirzepatide drugs like 'Mounjaro'

John's Wort was comparable to SSRIs for mild-to-moderate major depression, but SSRIs offer a more predictable pharmacokinetic profile and are easier to monitor [11]

They're simply for different phases of your same journey

Semaglutide, a medication originally developed for diabetes management, has garnered significant attention in recent years for its broader health benefits